Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Axiall (Specialty Phosgene Derivatives Business)

M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of chemicals. The business unit manufactures phosgene and its derivatives, which are used in the polymer, pharmaceutical and agricultural chemicals industries. It is the largest North American production facility of merchant phosgene derivatives, including chloroformates and acid chlorides.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Industrial Chemicals
Other Industries
Specialty Chemicals
Other Chemicals and Gases
Acquirer
Primary Office
  • La Porte, TX
  • United States

Axiall (Specialty Phosgene Derivatives Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Axiall (Specialty Phosgene Derivatives Business)‘s full profile, request access.

Request full access to PitchBook

Axiall (Specialty Phosgene Derivatives Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Axiall (Specialty Phosgene Derivatives Business)‘s full profile, request access.

Request full access to PitchBook

Axiall (Specialty Phosgene Derivatives Business) Executive Team (1)

Name Title Board
Seat
Contact
Info
Walter Sakowicz Business Director, Chlorine and Derivatives